| Title | Oral Proteins & Peptides Market: Growth, Size, Share, and Trends |
|---|
| URL | https://www.marketsandmarkets.com/Market-Reports/oral-proteins-peptides-market-194705708.html |
|---|
| Category | Fitness Health --> Health Articles |
|---|
| Meta Keywords | Oral Proteins & Peptides Market |
|---|
| Meta Description | Globally, North America is the largest market for oral proteins and peptides, and this trend is expected to continue during the forecast period. |
|---|
| Owner | Healthcare101 |
|---|
| Description |
|---|
| The market for oral proteins and peptides is projected to reach USD 20.36 billion by 2029 from USD 7.38 billion in 2024, at a CAGR of 22.5% from 2024 to 2029. Market growth is attributed to factors such as the increasing prevalence of chronic diseases (such as diabetes and gastroenterology & kidney diseases), advancements in drug delivery technologies, and patient preference & compliance for the oral route of drug administration. Semaglutide, a GLP-1 receptor agonist, accounted for the major share in the market due to the increasing prevalence of diabetes, obesity, and overweight. Novo Nordisk A/S (Denmark) also announced the development of another GLP-1 receptor agonist molecule for treating obesity and overweight. |
